1
|
Kamsa-Ard S, Luvira V, Suwanrungruang K,
Kamsa-Ard S, Luvira V, Santong C, Srisuk T, Pugkhem A,
Bhudhisawasdi V and Pairojkul C: Cholangiocarcinoma trends,
incidence, and relative survival in Khon Kaen, Thailand from 1989
through 2013: A population-based cancer registry study. J.
Epidemiol:1–8. 2018.PubMed/NCBI View Article : Google Scholar
|
2
|
Jusakul A, Kongpetch S and Teh BT:
Genetics of opisthorchis viverrini-related cholangiocarcinoma. Curr
Opin Gastroenterol. 28:258–263. 2015.PubMed/NCBI View Article : Google Scholar
|
3
|
Blechacz B: Cholangiocarcinoma: Current
knowledge and new developments. Gut Liver. 11:13–26.
2017.PubMed/NCBI View
Article : Google Scholar
|
4
|
Wongkham S and Silsirivanit A: State of
serum markers for detection of cholangiocarcinoma. Asian Pac J
Cancer Prev. 13:17–27. 2012.PubMed/NCBI
|
5
|
Tshering G, Dorji PW, Chaijaroenkul W and
Na-Bangchang K: Biomarkers for the diagnosis of cholangiocarcinoma.
Am J Trop Med Hyg. 98:1788–1797. 2018.PubMed/NCBI View Article : Google Scholar
|
6
|
Sripa B, Thinkhamrop B, Mairiang E, Laha
T, Kaewkes S, Sithithaworn P, Periago MV, Bhudhisawasdi V,
Yonglitthipagon P, Mulvenna J, et al: Elevated plasma IL-6
associates with increased risk of advanced fibrosis and
cholangiocarcinoma in individuals infected by opisthorchis
viverrini. PLoS Negl Trop Dis. 6(e1654)2012.PubMed/NCBI View Article : Google Scholar
|
7
|
Yongvanit P, Pinlaor S and Bartsch H:
Oxidative and nitrative DNA damage: Key events in
opisthorchiasis-induced carcinogenesis. Parasitol Int. 61:130–135.
2012.PubMed/NCBI View Article : Google Scholar
|
8
|
Hurst SD, Muchamuel T, Gorman DM, Gilbert
JM, Clifford T, Kwan S, Menon S, Seymour B, Jackson C, Kung TT, et
al: New IL-17 family members promote Th1 or Th2 responses in the
lung: In vivo function of the novel cytokine IL-25. J Immunol.
169:443–453. 2002.PubMed/NCBI View Article : Google Scholar
|
9
|
Saadoun D, Terrier B and Cacoub P:
Interleukin-25: Key regulator of inflammatory and autoimmune
diseases. Curr Pharm Des. 17:3781–3785. 2011.PubMed/NCBI View Article : Google Scholar
|
10
|
Terrier B, Bièche I, Maisonobe T,
Laurendeau I, Rosenzwajg M, Kahn JE, Diemert MC, Musset L, Vidaud
M, Sène D, et al: Interleukin-25: A cytokine linking eosinophils
and adaptive immunity in churg-strauss syndrome. Blood.
116:4523–4531. 2010.PubMed/NCBI View Article : Google Scholar
|
11
|
Fort MM, Cheung J, Yen D, Li J, Zurawski
SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, et al: IL-25
induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in
vivo. Immunity. 15:985–995. 2001.PubMed/NCBI View Article : Google Scholar
|
12
|
Yin SY, Jian FY, Chen YH, Chien SC, Hsieh
MC, Hsiao PW, Lee WH, Kuo YH and Yang NS: Induction of IL-25
secretion from tumour-associated fibroblasts suppresses mammary
tumour metastasis. Nat Commun. 7(11311)2016.PubMed/NCBI View Article : Google Scholar
|
13
|
Li J, Liao Y, Ding T, Wang B, Wang B, Yu
X, Chu Y, Xu J and Zheng L: Tumor-Infiltrating macrophages express
interleukin-25 and predict a favorable prognosis in patients with
gastric cancer after radical resection. Oncotarget. 7:11083–11093.
2016.PubMed/NCBI View Article : Google Scholar
|
14
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
18(357)2017.PubMed/NCBI View Article : Google Scholar
|
15
|
Tummanatsakun D, Proungvitaya T, Roytrakul
S, Limpaiboon T, Wongkham S, Wongkham C, Silsirivanit A, Somintara
O, Sangkhamanon S and Proungvitaya S: Serum apurinic/apyrimidinic
endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of
cholangiocarcinoma. Biomolecules. 26(413)2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Dupont WD and Plummer WD Jr: Power and
sample size calculations: A review and computer program. Control
Clin Trials. 11:116–128. 1990.PubMed/NCBI View Article : Google Scholar
|
17
|
Janan M, Proungvitaya S, Limpaiboon T,
Proungvitaya T, Roytrakul S, Wongkham C, Jearanaikoon P, Chur-in S
and Wongkham S: Serum adhesion molecule-1 (ICAM-1) as a potential
prognostic marker for cholangiocarcinoma patients. Asian Pac J
Cancer Prev. 13:107–114. 2012.PubMed/NCBI
|
18
|
Kim SW, Roh J and Park CS:
Immunohistochemistry for pathologists: Protocols, pitfalls, and
tips. J Pathol Transl Med. 50:411–418. 2016.PubMed/NCBI View Article : Google Scholar
|
19
|
Pierceall WE, Wolfe M, Suschak J, Chang H,
Chen Y, Sprott KM, Kutok JL, Quan S, Weaver DT and Ward BE:
Strategies for H-score normalization of preanalytical technical
variables with potential utility to immunohistochemical-based
biomarker quantitation in therapeutic reponse diagnostics. Anal
Cell Pathol (Amst). 34:159–168. 2011.PubMed/NCBI View Article : Google Scholar
|
20
|
Gillespie JW, Best CJ, Bichsel VE, Cole
KA, Greenhut SF, Hewitt SM, Ahram M, Gathright YB, Merino MJ,
Strausberg RL, et al: Evaluation of non-formalin tissue fixation
for molecular profiling studies. Am J Pathol. 160:449–457.
2002.PubMed/NCBI View Article : Google Scholar
|
21
|
De Petris L, Pernemalm M, Elmberger G,
Bergman P, Orre L, Lewensohn R and Lehtiö J: A novel method for
sample preparation of fresh lung cancer tissue for proteomics
analysis by tumor cell enrichment and removal of blood
contaminants. Proteome Sci. 8(9)2010.PubMed/NCBI View Article : Google Scholar
|
22
|
Ericsson C and Nistér M: Protein
extraction from solid tissue. Methods Mol Biol. 675:307–312.
2011.PubMed/NCBI View Article : Google Scholar
|
23
|
Lee JH, Hong CS, Lee S, Yang JE, Park Y
Il, Lee D, Hyeon T, Jung S and Paik SR: Radiating amyloid fibril
formation on the surface of lipid membranes through unit-assembly
of oligomeric species of α-synuclein. PLoS One.
7(e47580)2012.PubMed/NCBI View Article : Google Scholar
|
24
|
Lowry OH, Rosebrough NJ, Farr AL and
Randall RJ: Protein measurement with the folin phenol reagent. J
Biol Chem. 193:265–275. 1951.PubMed/NCBI
|
25
|
Kuhn M, Szklarczyk D, Pletscher-Frankild
S, Blicher TH, Von Mering C, Jensen LJ and Bork P: STITCH 4:
Integration of protein-chemical interactions with user data.
Nucleic Acids Res. 42:D401–D107. 2014.PubMed/NCBI View Article : Google Scholar
|
26
|
Szklarczyk D, Santos A, Von Mering C,
Jensen L and Bork P: STITCH 5: Augmenting protein-chemical
interaction networks with tissue and affinity data. Nucleic Acids
Res. 44:D380–D384. 2016.PubMed/NCBI View Article : Google Scholar
|
27
|
Gregory LG, Jones CP, Walker SA, Sawant D,
Gowers KH, Campbell GA, Mckenzie AN and Lloyd CM and Lloyd CM:
IL-25 drives remodelling in allergic airways disease induced by
house dust mite. Thorax. 68:82–90. 2013.PubMed/NCBI View Article : Google Scholar
|
28
|
Kaufhold S and Bonavida B: Central role of
snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res.
33(62)2014.PubMed/NCBI View Article : Google Scholar
|
29
|
Thelen TD, Green RM and Ziegler SF: Acute
blockade of IL-25 in a colitis associated colon cancer model leads
to increased tumor burden. Sci Rep. 6(25643)2016.PubMed/NCBI View Article : Google Scholar
|
30
|
Jiang Z, Chen J, Du X, Cheng H, Wang X and
Dong C: IL-25 blockade inhibits metastasis in breast cancer.
Protein Cell. 8:191–201. 2017.PubMed/NCBI View Article : Google Scholar
|
31
|
Ji Y and Zhang W: Th17 cells: Positive or
negative role in tumor. Cancer Immunol Immunother. 59:979–987.
2010.PubMed/NCBI View Article : Google Scholar
|
32
|
Furuta S, Jeng YM, Zhou L, Huang L, Kuhn
I, Bissell MJ and Lee WH: IL-25 causes apoptosis of
IL-25R-expressing breast cancer cells without toxicity to
nonmalignant cells. Sci Transl Med. 13(78ra31)2011.PubMed/NCBI View Article : Google Scholar
|
33
|
Benatar T, Cao MY, Lee Y, Lightfoot J,
Feng N, Gu X, Lee V, Jin H, Wang M, Wright JA and Young AH: IL-17E,
a proinflammatory cytokine, has antitumor efficacy against several
tumor types in vivo. Cancer Immunol Immunother. 59:805–817.
2010.PubMed/NCBI View Article : Google Scholar
|
34
|
Mikami Y, Takada Y, Hagihara Y and Kanai
T: Innate lymphoid cells in organ fibrosis. Cytokine Growth Factor
Rev. 42:27–36. 2018.PubMed/NCBI View Article : Google Scholar
|
35
|
Corrigan CJ, Wang W, Meng Q, Fang C, Wu H,
Reay V, Lv Z, Fan Y, An Y, Wang YH, et al: T-Helper cell type 2
(Th2) memory T cell-potentiating cytokine IL-25 has the potential
to promote angiogenesis in asthma. Proc Natl Acad Sci USA.
108:1579–1584. 2011.PubMed/NCBI View Article : Google Scholar
|
36
|
Wu F, Xu J, Huang Q, Han J, Duan L, Fan J,
Lv Z, Guo M, Hu G, Chen L, et al: The role of interleukin-17 in
lung cancer. Mediators Inflamm. 2016(8494079)2016.PubMed/NCBI View Article : Google Scholar
|
37
|
Lee J, Ho WH, Maruoka M, Corpuz RT,
Baldwin DT, Foster JS, Goddard AD, Yansura DG, Vandlen RL, Wood WI
and Gurney AL: IL-17E, a novel proinflammatory ligand for the IL-17
receptor homolog IL-17Rh1. J Biol Chem. 276:1660–1664.
2001.PubMed/NCBI View Article : Google Scholar
|
38
|
Huber MA, Azoitei N, Baumann B, Grünert S,
Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-κB is
essential for epithelial mesenchymal transition and metastasis in a
model of breast cancer progression. J Clin Invest. 114,
2004:569–581. 2004.PubMed/NCBI View Article : Google Scholar
|
39
|
Jayachandran A, Königshoff M, Yu H,
Rupniewska E, Hecker M, Klepetko W, Seeger W and Eickelberg O: SNAI
transcription factors mediate epithelial-mesenchymal transition in
lung fibrosis. Thorax. 64:1053–1061. 2009.PubMed/NCBI View Article : Google Scholar
|